スペイン の 皮膚 がん の 傾向: 腫瘍 の 種類 が 変化 し て いる 新興 の 疫病
Jorge Santos-Juanes1,2,3,4,5, Raquel Santos-Juanes2, Marta López-Pando2
1GRIDER, Grupo de Investigación en Dermatología, Universidad de Oviedo; 33006 Oviedo, Spain.
Journal of clinical medicine
|August 28, 2025
まとめ
アストゥリアスでは皮膚がん,特にメラノーマの発生率が著しく増加しています. メラノーマの早期発見は改善されていますが,COVID-19のパンデミックは医療へのアクセスに影響を与え,継続的な予防とスクリーニングの必要性を強調しています.
科学分野:
- 皮膚科
- 流行病学
- 腫瘍学
背景:
- 非メラノーマとメラノーマの皮膚がんの発生率の増加は,疫学的な理解を必要とします.
- 効果的なコミュニティの予防と医療資源の計画には 正確な発生データが必要です
研究 の 目的:
- HUCAでの皮膚腫瘍診断 (2014-2023) を量化する.
- 基礎細胞癌 (BCC),状細胞癌 (SCC),およびメラノーマの時間的な傾向を説明します.
- メラノーマの臨床/病原学的特徴を分析し,発生率を推定する.
主な方法:
- HUCAの病理学登録データを用いた遡及的研究.
- 747人のBCC,2689人のSCC,そして585人のメラノーマ症例の分析
- EPIDAT 4.2 とヨーロッパ標準人口を用いた年齢標準化発生率の計算.
主要な成果:
- 2014年から2023年の間にBCC症例は50%増加し,SCCは80%増加し,メラノーマは159%増加しました.
- メラノマの発生率は10万人に8.85から18.50に増加しました
- 皮膚科医によって診断されたメラノーマの89%; 33. 1%はメラノーマ in situでした.
結論:
- アストゥリアス州では皮膚がん,特にメラノーマが顕著に増加している.
- メラノーマの診断の増加は 早期発見の改善を示唆しています
- COVID-19はケアへのアクセスに影響を与え,継続的な予防とスクリーニングが不可欠です.
関連する概念動画
Skin Cancer
4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Changes in Skin Color: Clinical Perspectives
2.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.2K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


